OTC : BIOGY

BioGaia AB (publ)

$11 USD

$0 (0.0%)

Volume
0
Average Volume
49
Market Capitalization
$1.11B
P/E Ratio
38.05
Dividend Yield
3.21%
Price Target
Year High
$11.46
Year Low
$8.79
Day High
—
Day Low
—
Payout Ratio
$2.10
Current Ratio
$4.94
Company Overview

OTC

Theresa Agnew

Drug Manufacturers - Specialty & Generic

Healthcare

BIOGY

243

SE

USD

https://www.biogaiagroup.com

46 8 55 52 93 00

09072J102

0001572957

Liquidity Metrics

0.00

4.94

4.94

3.27

2.10

Sales & Valuation

$1.54B

7.96

9.00

36.47

3.33

Profitability

$3.29

$332.76M

21.49%

27.25%

27.58%

25.98%

P/E Metrics

38.05

1.79

1.79

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Poll Results

About BioGaia AB (publ) (OTC:BIOGY) Stock

BioGaia AB (publ) is a global enterprise dedicated to the development, marketing, and sale of probiotic products, all backed by documented health benefits. The company organizes its activities into three primary divisions: Pediatrics, Adult Health, and 'Other'. Within the Pediatric segment, BioGaia provides items such as liquid drops, oral rehydration solutions, and gut health tablets, alongside supplying probiotic cultures for integration into infant formula. The Adult Health segment offers both digestive health tablets and oral hygiene lozenges, as well as providing cultures that are incorporated into dairy products by its licensees. The 'Other' segment focuses on delivering packaging solutions. BioGaia's product portfolio addresses a wide array of health conditions, including infantile ... colic and digestive problems in children, acute and antibiotic-associated diarrhea, gingivitis, periodontal disease, general wellness, Helicobacter pylori infections (the bacterium causing gastric ulcers), and low bone density. All of the company's products are sold under the BioGaia brand. Founded in 1990, BioGaia AB (publ) is headquartered in Stockholm, Sweden.

BioGaia AB (publ) (BIOGY) Q2 2026 Earnings Call Transcript

2026-07-17 14:46:16

BioGaia AB (publ) (BIOGY) Q2 2026 Earnings Call Transcript

Frequently Asked Questions

What is the current BioGaia AB (publ) (BIOGY) stock price?

BioGaia AB (publ)(OTC:BIOGY) stock price is $11 in the last trading session. During the trading session, BIOGY stock reached the peak price of $11.46 while $8.79 was the lowest point it dropped to. The percentage change in BIOGY stock occurred in the recent session was 0.0% while the dollar amount for the price change in BIOGY stock was $0.

BIOGY's industry and sector of operation?

The OTC listed BIOGY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of BIOGY?

Gianfranco Grompone | Chief Scentific Officer
Angelika Kjelldorff | Chief Human Resources Officer
Caroline Mofors | Executive Vice President & Chief Legal Officer
Alexander Kotsinas | Executive Vice President & Chief Financial Officer
Darryl Mallette | Managing Director Canada

How many employees does BIOGY have?

Number of BIOGY employees currently stands at 243. BIOGY operates from Kungsbroplan 3, Stockholm, AB 112 27, SE.

Link for BIOGY official website?

Official Website of BIOGY is: https://www.biogaiagroup.com

How do I contact BIOGY?

BIOGY could be contacted at phone #46 8 55 52 93 00 and can also be accessed through its website. BIOGY operates from Kungsbroplan 3, Stockholm, AB 112 27, SE.

How many shares of BIOGY are traded daily?

The average number of BIOGY shares traded daily for last 3 months was 49.

What is the market cap of BIOGY currently?

The market value of BIOGY currently stands at $1.11B with its latest stock price at $11